Pacific Biosciences of California, Inc. (PACB)
1.30
+0.02
(+1.56%)
USD |
NASDAQ |
Sep 02, 10:59
Pacific Biosciences of California Cash from Investing (Quarterly) : 40.07M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.07M |
| March 31, 2026 | 35.86M |
| December 31, 2025 | 26.03M |
| September 30, 2025 | 18.90M |
| June 30, 2025 | 25.28M |
| March 31, 2025 | 45.23M |
| December 31, 2024 | 58.24M |
| September 30, 2024 | 23.06M |
| June 30, 2024 | 76.84M |
| March 31, 2024 | -34.14M |
| December 31, 2023 | -66.58M |
| September 30, 2023 | 242.32M |
| June 30, 2023 | -98.59M |
| March 31, 2023 | -72.55M |
| December 31, 2022 | 80.40M |
| September 30, 2022 | 53.91M |
| June 30, 2022 | -60.28M |
| March 31, 2022 | 42.05M |
| December 31, 2021 | 65.75M |
| September 30, 2021 | -291.65M |
| June 30, 2021 | -460.81M |
| March 31, 2021 | 8.17M |
| December 31, 2020 | -98.50M |
| September 30, 2020 | -63.64M |
| June 30, 2020 | -2.859M |
| Date | Value |
|---|---|
| March 31, 2020 | -54.33M |
| December 31, 2019 | -3.408M |
| September 30, 2019 | 19.66M |
| June 30, 2019 | 7.812M |
| March 31, 2019 | 37.98M |
| December 31, 2018 | -5.513M |
| September 30, 2018 | -37.34M |
| June 30, 2018 | 12.19M |
| March 31, 2018 | -7.749M |
| December 31, 2017 | 10.68M |
| September 30, 2017 | 4.883M |
| June 30, 2017 | -42.59M |
| March 31, 2017 | 25.48M |
| December 31, 2016 | 6.672M |
| September 30, 2016 | 10.86M |
| June 30, 2016 | -9.16M |
| March 31, 2016 | -23.24M |
| December 31, 2015 | -22.43M |
| September 30, 2015 | 14.57M |
| June 30, 2015 | 1.17M |
| March 31, 2015 | 15.30M |
| December 31, 2014 | -1.509M |
| September 30, 2014 | 12.70M |
| June 30, 2014 | 0.179M |
| March 31, 2014 | 8.198M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Illumina, Inc. | -122.00M |
| Danaher Corp. | -10.15B |
| Agilent Technologies, Inc. | -1.032B |
| Bio-Rad Laboratories, Inc. | -66.70M |
| Thermo Fisher Scientific, Inc. | 164.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.58M |
| Cash from Financing (Quarterly) | 0.255M |
| Free Cash Flow | -130.48M |
| Free Cash Flow Per Share (Quarterly) | -0.1262 |
| Free Cash Flow to Equity (Quarterly) | -41.93M |
| Free Cash Flow to Firm (Quarterly) | -37.08M |
| Free Cash Flow Yield | -32.93% |